United States Antimony Cash & Equivalents Growth & History (UAMY)
United States Antimony's cash and equivalents was $30.5M for fiscal 2025.
View full United States Antimony company overviewUnited States Antimony annual cash and equivalents history
| Fiscal year | Period ended | Cash and equivalents | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $30.5M | $12.3M | +67.81% |
| 2024 | 2024-12-31 | $18.2M | $6.3M | +52.71% |
| 2023 | 2023-12-31 | $11.9M | −$7.2M | −37.57% |
| 2022 | 2022-12-31 | $19.1M | −$2.3M | −10.78% |
| 2021 | 2021-12-31 | $21.4M | $20.6M | +2857.33% |
| 2020 | 2020-12-31 | $722,377 | $606,871 | +525.40% |
| 2019 | 2019-12-31 | $115,506 | $58,856 | +103.89% |
| 2018 | 2018-12-31 | $56,650 | $28,663 | +102.42% |
| 2017 | 2017-12-31 | $27,987 | $17,930 | +178.28% |
| 2016 | 2016-12-31 | $10,057 | −$123,486 | −92.47% |
| 2015 | 2015-12-31 | $133,543 | $9,860 | +7.97% |
| 2014 | 2014-12-31 | $123,683 | $103,340 | +507.99% |
| 2013 | 2013-12-31 | $20,343 | −$980,468 | −97.97% |
| 2012 | 2012-12-31 | $1.0M | $995,384 | +18341.33% |
| 2011 | 2011-12-31 | $5,427 | −$443,434 | −98.79% |
| 2010 | 2010-12-31 | $448,861 | $268,248 | +148.52% |
| 2009 | 2009-12-31 | $180,613 | — | — |
United States Antimony quarterly cash and equivalents
| Fiscal quarter | Period ended | Cash and equivalents | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $42.3M | $36.4M | +627.48% |
| Q1 2026 | 2026-03-31 | $3.4M | −$15.5M | −82.04% |
| Q4 2025 | 2025-12-31 | $30.5M | $12.3M | +67.81% |
| Q3 2025 | 2025-09-30 | $18.5M | $5.5M | +42.42% |
| Q2 2025 | 2025-06-30 | $5.8M | −$6.6M | −53.13% |
| Q1 2025 | 2025-03-31 | $18.8M | $6.9M | +57.82% |
| Q4 2024 | 2024-12-31 | $18.2M | $6.3M | +52.71% |
| Q3 2024 | 2024-09-30 | $13.0M | $104,140 | +0.81% |
| Q2 2024 | 2024-06-30 | $12.4M | −$1.3M | −9.47% |
| Q1 2024 | 2024-03-31 | $11.9M | −$3.4M | −22.26% |
| Q4 2023 | 2023-12-31 | $11.9M | −$7.2M | −37.57% |
| Q3 2023 | 2023-09-30 | $12.9M | $5.2M | +67.98% |
| Q2 2023 | 2023-06-30 | $13.7M | $5.3M | +63.53% |
| Q1 2023 | 2023-03-31 | $15.4M | −$6.0M | −28.19% |
| Q4 2022 | 2022-12-31 | $19.1M | −$2.3M | −10.78% |
| Q3 2022 | 2022-09-30 | $7.7M | −$13.9M | −64.48% |
| Q2 2022 | 2022-06-30 | $8.4M | −$14.1M | −62.67% |
| Q1 2022 | 2022-03-31 | $21.4M | −$1.7M | −7.39% |
| Q4 2021 | 2021-12-31 | $21.4M | $20.6M | +2857.33% |
| Q3 2021 | 2021-09-30 | $21.6M | $20.1M | +1344.80% |
| Q2 2021 | 2021-06-30 | $22.4M | $22.3M | +18067.87% |
| Q1 2021 | 2021-03-31 | $23.1M | $23.1M | +100037.01% |
| Q4 2020 | 2020-12-31 | $722,377 | $606,871 | +525.40% |
| Q3 2020 | 2020-09-30 | $1.5M | $1.4M | +1979.89% |
| Q2 2020 | 2020-06-30 | $123,415 | $77,653 | +169.69% |
| Q1 2020 | 2020-03-31 | $23,068 | −$20,436 | −46.97% |
| Q4 2019 | 2019-12-31 | $115,506 | $58,856 | +103.89% |
| Q3 2019 | 2019-09-30 | $71,758 | −$447,524 | −86.18% |
| Q2 2019 | 2019-06-30 | $45,762 | $29,884 | +188.21% |
| Q1 2019 | 2019-03-31 | $43,504 | $31,123 | +251.38% |
| Q4 2018 | 2018-12-31 | $56,650 | $28,663 | +102.42% |
| Q3 2018 | 2018-09-30 | $519,282 | $491,706 | +1783.09% |
| Q2 2018 | 2018-06-30 | $15,878 | −$8,672 | −35.32% |
| Q1 2018 | 2018-03-31 | $12,381 | $1,252 | +11.25% |
| Q4 2017 | 2017-12-31 | $27,987 | $17,930 | +178.28% |
| Q3 2017 | 2017-09-30 | $27,576 | −$15,742 | −36.34% |
| Q2 2017 | 2017-06-30 | $24,550 | −$58,392 | −70.40% |
| Q1 2017 | 2017-03-31 | $11,129 | −$126,535 | −91.92% |
| Q4 2016 | 2016-12-31 | $10,057 | −$123,486 | −92.47% |
| Q3 2016 | 2016-09-30 | $43,318 | −$160,006 | −78.70% |
| Q2 2016 | 2016-06-30 | $82,942 | $8,817 | +11.89% |
| Q1 2016 | 2016-03-31 | $137,664 | $1,578 | +1.16% |
| Q4 2015 | 2015-12-31 | $133,543 | $9,860 | +7.97% |
| Q3 2015 | 2015-09-30 | $203,324 | −$334,850 | −62.22% |
| Q2 2015 | 2015-06-30 | $74,125 | −$1.5M | −95.28% |
| Q1 2015 | 2015-03-31 | $136,086 | $131,235 | +2705.32% |
| Q4 2014 | 2014-12-31 | $123,683 | $103,340 | +507.99% |
| Q3 2014 | 2014-09-30 | $538,174 | $453,332 | +534.32% |
| Q2 2014 | 2014-06-30 | $1.6M | $1.2M | +329.72% |
| Q1 2014 | 2014-03-31 | $4,851 | $4,851 | — |
| Q4 2013 | 2013-12-31 | $20,343 | −$980,468 | −97.97% |
| Q3 2013 | 2013-09-30 | $84,842 | −$2.3M | −96.43% |
| Q2 2013 | 2013-06-30 | $365,694 | −$3.1M | −89.38% |
| Q1 2013 | 2013-03-31 | $0 | −$1.4M | — |
| Q4 2012 | 2012-12-31 | $1.0M | $995,384 | +18341.33% |
| Q3 2012 | 2012-09-30 | $2.4M | $1.9M | +365.04% |
| Q2 2012 | 2012-06-30 | $3.4M | $3.1M | +995.85% |
| Q1 2012 | 2012-03-31 | $1.4M | — | — |
| Q4 2011 | 2011-12-31 | $5,427 | −$443,434 | −98.79% |
| Q3 2011 | 2011-09-30 | $511,070 | — | — |
| Q2 2011 | 2011-06-30 | $314,278 | — | — |
| Q4 2010 | 2010-12-31 | $448,861 | — | — |
United States Antimony cash and equivalents trends
Over the last five fiscal years, United States Antimony's cash and equivalents increased from $722,377 to $30.5M, a change of $29.8M. The latest reported quarter, Q2 2026, shows $42.3M.
What cash and equivalents mean
Cash and cash equivalents, often described as cash on hand, are highly liquid resources available for near-term obligations, investment, acquisitions, debt repayment, dividends, or share repurchases. This measure does not include short-term investments reported separately.
Reported cash and equivalents
TickerStat standardizes cash and cash equivalents reported on the balance sheet. Restricted cash is included only when the company reports it within the selected consolidated cash concept. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review United States Antimony source filings ↗